Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

BacterioFiles

461: Ingrained Invader Inhibits Infectors

06 Sep 2021

Description

This episode: Training a phage strain on bacteria can increase its ability to control those bacteria for much longer than an untrained phage! Download Episode (5.7 MB, 8.3 minutes) Show notes: Microbe of the episode: Pepper yellow leaf curl Indonesia virus   News item   Takeaways With resistance to antibiotics spreading more and more among deadly bacteria, finding alternatives to treat infections is becoming more important. One option is phage therapy, using viruses that infect bacteria to weaken or wipe out pathogens, but this can be tricky. Sometimes it takes too long to prepare an effective population of phage for treatment, and sometimes the target pathogen evolves resistance to the phage too quickly   In this study, a phage that was trained, or pre-evolved, to infect specific bacteria more effectively, was able to dominate the population consistently and prevent it from becoming fully resistant. For comparison, against an untrained strain of the same phage, the bacteria developed almost complete resistance after several days.   Journal Paper: Borin JM, Avrani S, Barrick JE, Petrie KL, Meyer JR. 2021. Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance. Proc Natl Acad Sci 118. Other interesting stories: Engineered gut bacteria could sense and indicate bowel inflammation   Email questions or comments to bacteriofiles at gmail dot com. Thanks for listening! Subscribe: Apple Podcasts, Google Podcasts, Android, or RSS. Support the show at Patreon, or check out the show at Twitter or Facebook.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.